Lemaitre Vascular (LMAT) Shares Outstanding (Diluted Average) (2010 - 2025)
Lemaitre Vascular (LMAT) reported Shares Outstanding (Diluted Average) of $22.9 million for Q2 2025, up 1.05% year-over-year from $22.7 million in Q2 2024, and little changed on a QoQ basis from $22.9 million in Q1 2025.
Lemaitre Vascular (LMAT) has 15 years of Shares Outstanding (Diluted Average) data on file, last reported at $22.9 million in Q2 2025.
- Quarterly Shares Outstanding (Diluted Average) rose 1.05% year-over-year to $22.9 million in Q2 2025, while the trailing twelve-month figure through Jun 2025 was $22.9 million (up 1.05% YoY) and the FY2024 annual result came in at $22.8 million, up 1.59% from the prior year.
- Shares Outstanding (Diluted Average) held at $22.9 million in Q2 2025 per LMAT's latest filing, from $22.9 million in the prior quarter.
- Across five years, Shares Outstanding (Diluted Average) topped out at $22.9 million in Q1 2025 and bottomed at $163000.0 in Q1 2023.
- The 5-year median for Shares Outstanding (Diluted Average) is $22.2 million (2022), against an average of $17.3 million.
- The widest annual swing landed in 2023, when Shares Outstanding (Diluted Average) tumbled 99.26%; it then soared 13746.63% in 2024.
- Tracing LMAT's Shares Outstanding (Diluted Average) over 5 years: stood at $21.5 million in 2021, then grew by 3.24% to $22.2 million in 2022, then increased by 1.14% to $22.4 million in 2023, then rose by 1.59% to $22.8 million in 2024, then grew by 0.51% to $22.9 million in 2025.
- Per Business Quant, the three latest LMAT Shares Outstanding (Diluted Average) figures stand at $22.9 million (Q2 2025), $22.9 million (Q1 2025), and $22.8 million (Q4 2024).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares (Diluted Avg.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 156.17 Bn | 151.78 Bn | 1.83 Bn | 359.80 Mn |
| 2 | Becton Dickinson | 41.51 Bn | 40.49 Bn | 2.15 Bn | - |
| 3 | Resmed | 30.43 Bn | 28.77 Bn | 890.98 Mn | 145.72 Mn |
| 4 | West Pharmaceutical Services | 22.78 Bn | 22.26 Bn | 296.40 Mn | 72.40 Mn |
| 5 | Solventum | 13.39 Bn | 13.39 Bn | 1.10 Bn | 175.50 Mn |
| 6 | Cooper Companies | 12.33 Bn | 12.20 Bn | 695.20 Mn | 196.70 Mn |
| 7 | Align Technology | 11.65 Bn | 10.59 Bn | 736.59 Mn | 71.61 Mn |
| 8 | Baxter International | 9.81 Bn | 7.77 Bn | 891.00 Mn | 515.00 Mn |
| 9 | Aptargroup | 7.39 Bn | 7.19 Bn | 351.91 Mn | 64.83 Mn |
| 10 | Lemaitre Vascular | 2.28 Bn | 1.91 Bn | 48.40 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2025 | 22.90 Mn |
| Mar 31, 2025 | 22.90 Mn |
| Dec 31, 2024 | 22.78 Mn |
| Sep 30, 2024 | 360,000.00 |
| Jun 30, 2024 | 22.66 Mn |
| Mar 31, 2024 | 22.57 Mn |
| Dec 31, 2023 | 22.42 Mn |
| Sep 30, 2023 | 22.48 Mn |
| Jun 30, 2023 | 209,000.00 |
| Mar 31, 2023 | 163,000.00 |
| Dec 31, 2022 | 22.17 Mn |
| Sep 30, 2022 | 22.22 Mn |
| Jun 30, 2022 | 22.13 Mn |
| Mar 31, 2022 | 22.10 Mn |
| Dec 31, 2021 | 21.48 Mn |
| Sep 30, 2021 | 331,000.00 |
| Jun 30, 2021 | 20.96 Mn |
| Mar 31, 2021 | 20.85 Mn |
| Dec 31, 2020 | 233,000.00 |
| Sep 30, 2020 | 233,000.00 |
| Mar 31, 2020 | 20.44 Mn |
| Dec 31, 2019 | 513,000.00 |
| Sep 30, 2019 | 20.28 Mn |
| Jun 30, 2019 | 20.25 Mn |
| Mar 31, 2019 | 565,000.00 |
| Dec 31, 2018 | 20.24 Mn |
| Sep 30, 2018 | 20.29 Mn |
| Jun 30, 2018 | 20.24 Mn |
| Mar 31, 2018 | 898,000.00 |
| Dec 31, 2017 | 20.03 Mn |
| Dec 31, 2016 | 756,000.00 |
| Jun 30, 2014 | 16.29 Mn |
| Mar 31, 2014 | 15.59 Mn |
| Dec 31, 2013 | 15.76 Mn |
| Sep 30, 2013 | 15.78 Mn |
| Jun 30, 2013 | 15.70 Mn |
| Mar 31, 2013 | 15.65 Mn |
| Dec 31, 2012 | 15.64 Mn |
| Sep 30, 2012 | 15.61 Mn |
| Jun 30, 2012 | 15.68 Mn |
| Mar 31, 2012 | 15.73 Mn |
| Dec 31, 2011 | 15.99 Mn |
| Sep 30, 2011 | 16.05 Mn |
| Jun 30, 2011 | 16.07 Mn |
| Mar 31, 2011 | 16.04 Mn |
| Dec 31, 2010 | 16.11 Mn |
| Sep 30, 2010 | 16.16 Mn |
| Jun 30, 2010 | 16.05 Mn |